Press release MHRA - Nurofen / seroquel antipsychotic

[Guest guest]

Press release Date: 25 August 2011 Time: 16:00 Subject: Public

warned to be extra vigilant when purchasing and using Nurofen Plus

Contact: Press Office 020 3080 7651

or press.office@... <mailto:press.office@...>

Out-of-hours 07770 446 189

The MHRA is advising people to be extra vigilant if taking Nurofen Plus

pain relief tablets following reports that the anti-psychotic drug,

Seroquel XL 50mg, has been found within some Nurofen Plus packets.

Nurofen Plus tablets are a pharmacy only product. Three defective packs

have been found in pharmacies across the UK.

The batch numbers and details which can be found on the affected Nurofen

Plus packets are:

Pack Size Batch Number Expiry Date Product License No 32 Tablets 13JJ

03/2014 00327 / 0082 32 Tablets 57JJ 05/2014 00063 / 0376 32

Tablets 49JJ 05/2014 00063 / 0376

The large capsule-shaped Seroquel XL 50 mg tablets can be identified by

their gold and black packaging.

The smaller Nurofen Plus tablets can be identified by their silver and

black packaging.

Ian Holloway from the MHRA's Defective Medicines Report Centre

(DMRC) said, " People should check to see if they have any affected

packets of Nurofen Plus. If you do, return them to the pharmacy where

you bought them from. You can also report this to the MHRA's DMRC on

020 3080 6574.

" If you have taken a tablet and you have any questions, speak to

your GP. "

Notes to Editor

1. The MHRA has today issued a Class 4 Drug Alert (Caution in Use) to

pharmacies

<http://www.mhra.gov.uk/NewsCentre/Pressreleases/ssLINK/CON126220> .

2. Nurofen Plus tablets are pharmacy only status. The company that holds

the licence is Reckitt Benckiser (UK) Ltd. The medicine is used as a

painkiller for the short term treatment of acute, moderate pains which

are not relieved by paracetamol, ibuprofen or aspirin alone. It contains

codeine. 3. Seroquel XL 50mg tablets are prescription-only. The

company that holds the original licence is AstraZeneca UK Ltd. The

medicine is an anti-psychotic used to treat several illnesses such as

schizophrenia, mania and bipolar depression. 4. The MHRA is the

government agency responsible for ensuring that medicines and medical

devices work, and are acceptably safe. No product is risk-free.

Underpinning all our work lie robust and fact-based judgements to ensure

that the benefits to patients and the public justify the risks. We keep

watch over medicines and devices, and take any necessary action to

protect the public promptly if there is a problem. We encourage everyone

=96 the public and healthcare professionals as well as the industry

=96 to tell us about any problems with a medicine or medical device,

so that we can investigate and take any necessary action.

Download documents:

* [PDF file (opens in new window)] Press release: Public warned to

be extra vigilant when purchasing and using Nurofen Plus (53Kb)

<http://www.mhra.gov.uk/home/groups/comms-po/documents/news/con126228.pd\

f>

[Guest guest]

Press release Date: 25 August 2011 Time: 16:00 Subject: Public

warned to be extra vigilant when purchasing and using Nurofen Plus

Contact: Press Office 020 3080 7651

or press.office@... <mailto:press.office@...>

Out-of-hours 07770 446 189

The MHRA is advising people to be extra vigilant if taking Nurofen Plus

pain relief tablets following reports that the anti-psychotic drug,

Seroquel XL 50mg, has been found within some Nurofen Plus packets.

Nurofen Plus tablets are a pharmacy only product. Three defective packs

have been found in pharmacies across the UK.

The batch numbers and details which can be found on the affected Nurofen

Plus packets are:

Pack Size Batch Number Expiry Date Product License No 32 Tablets 13JJ

03/2014 00327 / 0082 32 Tablets 57JJ 05/2014 00063 / 0376 32

Tablets 49JJ 05/2014 00063 / 0376

The large capsule-shaped Seroquel XL 50 mg tablets can be identified by

their gold and black packaging.

The smaller Nurofen Plus tablets can be identified by their silver and

black packaging.

Ian Holloway from the MHRA's Defective Medicines Report Centre

(DMRC) said, " People should check to see if they have any affected

packets of Nurofen Plus. If you do, return them to the pharmacy where

you bought them from. You can also report this to the MHRA's DMRC on

020 3080 6574.

" If you have taken a tablet and you have any questions, speak to

your GP. "

Notes to Editor

1. The MHRA has today issued a Class 4 Drug Alert (Caution in Use) to

pharmacies

<http://www.mhra.gov.uk/NewsCentre/Pressreleases/ssLINK/CON126220> .

2. Nurofen Plus tablets are pharmacy only status. The company that holds

the licence is Reckitt Benckiser (UK) Ltd. The medicine is used as a

painkiller for the short term treatment of acute, moderate pains which

are not relieved by paracetamol, ibuprofen or aspirin alone. It contains

codeine. 3. Seroquel XL 50mg tablets are prescription-only. The

company that holds the original licence is AstraZeneca UK Ltd. The

medicine is an anti-psychotic used to treat several illnesses such as

schizophrenia, mania and bipolar depression. 4. The MHRA is the

government agency responsible for ensuring that medicines and medical

devices work, and are acceptably safe. No product is risk-free.

Underpinning all our work lie robust and fact-based judgements to ensure

that the benefits to patients and the public justify the risks. We keep

watch over medicines and devices, and take any necessary action to

protect the public promptly if there is a problem. We encourage everyone

=96 the public and healthcare professionals as well as the industry

=96 to tell us about any problems with a medicine or medical device,

so that we can investigate and take any necessary action.

Download documents:

* [PDF file (opens in new window)] Press release: Public warned to

be extra vigilant when purchasing and using Nurofen Plus (53Kb)

<http://www.mhra.gov.uk/home/groups/comms-po/documents/news/con126228.pd\

f>

[Guest guest]

Press release Date: 25 August 2011 Time: 16:00 Subject: Public

warned to be extra vigilant when purchasing and using Nurofen Plus

Contact: Press Office 020 3080 7651

or press.office@... <mailto:press.office@...>

Out-of-hours 07770 446 189

The MHRA is advising people to be extra vigilant if taking Nurofen Plus

pain relief tablets following reports that the anti-psychotic drug,

Seroquel XL 50mg, has been found within some Nurofen Plus packets.

Nurofen Plus tablets are a pharmacy only product. Three defective packs

have been found in pharmacies across the UK.

The batch numbers and details which can be found on the affected Nurofen

Plus packets are:

Pack Size Batch Number Expiry Date Product License No 32 Tablets 13JJ

03/2014 00327 / 0082 32 Tablets 57JJ 05/2014 00063 / 0376 32

Tablets 49JJ 05/2014 00063 / 0376

The large capsule-shaped Seroquel XL 50 mg tablets can be identified by

their gold and black packaging.

The smaller Nurofen Plus tablets can be identified by their silver and

black packaging.

Ian Holloway from the MHRA's Defective Medicines Report Centre

(DMRC) said, " People should check to see if they have any affected

packets of Nurofen Plus. If you do, return them to the pharmacy where

you bought them from. You can also report this to the MHRA's DMRC on

020 3080 6574.

" If you have taken a tablet and you have any questions, speak to

your GP. "

Notes to Editor

1. The MHRA has today issued a Class 4 Drug Alert (Caution in Use) to

pharmacies

<http://www.mhra.gov.uk/NewsCentre/Pressreleases/ssLINK/CON126220> .

2. Nurofen Plus tablets are pharmacy only status. The company that holds

the licence is Reckitt Benckiser (UK) Ltd. The medicine is used as a

painkiller for the short term treatment of acute, moderate pains which

are not relieved by paracetamol, ibuprofen or aspirin alone. It contains

codeine. 3. Seroquel XL 50mg tablets are prescription-only. The

company that holds the original licence is AstraZeneca UK Ltd. The

medicine is an anti-psychotic used to treat several illnesses such as

schizophrenia, mania and bipolar depression. 4. The MHRA is the

government agency responsible for ensuring that medicines and medical

devices work, and are acceptably safe. No product is risk-free.

Underpinning all our work lie robust and fact-based judgements to ensure

that the benefits to patients and the public justify the risks. We keep

watch over medicines and devices, and take any necessary action to

protect the public promptly if there is a problem. We encourage everyone

=96 the public and healthcare professionals as well as the industry

=96 to tell us about any problems with a medicine or medical device,

so that we can investigate and take any necessary action.

Download documents:

* [PDF file (opens in new window)] Press release: Public warned to

be extra vigilant when purchasing and using Nurofen Plus (53Kb)

<http://www.mhra.gov.uk/home/groups/comms-po/documents/news/con126228.pd\

f>

[Guest guest]

Press release Date: 25 August 2011 Time: 16:00 Subject: Public

warned to be extra vigilant when purchasing and using Nurofen Plus

Contact: Press Office 020 3080 7651

or press.office@... <mailto:press.office@...>

Out-of-hours 07770 446 189

The MHRA is advising people to be extra vigilant if taking Nurofen Plus

pain relief tablets following reports that the anti-psychotic drug,

Seroquel XL 50mg, has been found within some Nurofen Plus packets.

Nurofen Plus tablets are a pharmacy only product. Three defective packs

have been found in pharmacies across the UK.

The batch numbers and details which can be found on the affected Nurofen

Plus packets are:

Pack Size Batch Number Expiry Date Product License No 32 Tablets 13JJ

03/2014 00327 / 0082 32 Tablets 57JJ 05/2014 00063 / 0376 32

Tablets 49JJ 05/2014 00063 / 0376

The large capsule-shaped Seroquel XL 50 mg tablets can be identified by

their gold and black packaging.

The smaller Nurofen Plus tablets can be identified by their silver and

black packaging.

Ian Holloway from the MHRA's Defective Medicines Report Centre

(DMRC) said, " People should check to see if they have any affected

packets of Nurofen Plus. If you do, return them to the pharmacy where

you bought them from. You can also report this to the MHRA's DMRC on

020 3080 6574.

" If you have taken a tablet and you have any questions, speak to

your GP. "

Notes to Editor

1. The MHRA has today issued a Class 4 Drug Alert (Caution in Use) to

pharmacies

<http://www.mhra.gov.uk/NewsCentre/Pressreleases/ssLINK/CON126220> .

2. Nurofen Plus tablets are pharmacy only status. The company that holds

the licence is Reckitt Benckiser (UK) Ltd. The medicine is used as a

painkiller for the short term treatment of acute, moderate pains which

are not relieved by paracetamol, ibuprofen or aspirin alone. It contains

codeine. 3. Seroquel XL 50mg tablets are prescription-only. The

company that holds the original licence is AstraZeneca UK Ltd. The

medicine is an anti-psychotic used to treat several illnesses such as

schizophrenia, mania and bipolar depression. 4. The MHRA is the

government agency responsible for ensuring that medicines and medical

devices work, and are acceptably safe. No product is risk-free.

Underpinning all our work lie robust and fact-based judgements to ensure

that the benefits to patients and the public justify the risks. We keep

watch over medicines and devices, and take any necessary action to

protect the public promptly if there is a problem. We encourage everyone

=96 the public and healthcare professionals as well as the industry

=96 to tell us about any problems with a medicine or medical device,

so that we can investigate and take any necessary action.

Download documents:

* [PDF file (opens in new window)] Press release: Public warned to

be extra vigilant when purchasing and using Nurofen Plus (53Kb)

<http://www.mhra.gov.uk/home/groups/comms-po/documents/news/con126228.pd\

f>